|
|
|
| Webinar: Building an Effective Contamination Control Strategy for Sterile Filtration | It is important that end-users understand what factors to consider when executing a CCS for sterile filtration and the types of risk assessments that should be conducted. Join us on August 13th with Cytiva as we discuss filter selection, integrity testing, filter validation and considerations for performing pre-use post sterilization integrity testing (PUPSIT). Click here to learn more. |
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
|
By Yadnyesh Patel, microbiology subject matter expert | In this second article of a planned series about bacterial endotoxin testing, the author shares best practices about prerequisites and reagent preparation for a gel clot Limulus amebocyte lysate (LAL) test. |
|
|
| Constraints And Solutions For Biopharmaceutical Manufacturing | Article | By Scott Merz, Asahi Kasei Bioprocess | Dissect the reasons for capacity bottlenecks stemming from process development scope, downstream chromatography, and equipment constraints, and delve into the potential solutions associated with each. |
|
|
|
|
|
|
| Building A Fully Single-Use Process: Protein A Membrane Devices | Case Study | By Shunsuke Shiina, Ph.D., Chase Snyder, Neha Saxena, Ph.D., and Rodrigo Gonzalez, Ph.D., AGC Biologics | Learn how a fully disposable upstream and downstream platform process in antibody production can increase production timelines, enhance scalability, and reduce risk in biologics manufacturing. |
|
|
| Sustainability Goals Impacting Biopharma | Q&A | Purolite, An Ecolab Company | What are some of the new trends in the pharmaceutical industry spurred on by mAbs and other advanced therapies, and how is sustainability influencing business practices? |
|
|
|
| Process Intensification And Connected Processing For mAb Manufacturing | Poster | By Sanket H. Jadhav, Abijar Bhori, Himanshu Gadgil, and Priyanka Gupta, Sartorius | Here, we present a proof of concept, demonstrating how a batch process for mAb purification can be transformed into an intensified process and then a connected process in a strategic, stepwise manner. |
|
|
|
|
|
| AI and machine learning are the buzzwords of the decade, often accompanied by lofty promises — but what do they really mean for biopharma? How can these technologies be adopted to improve biomanufacturing processes, testing, and quality? Join Bioprocess Online Live for an exploration into the practical applications of AI/ML in biomanufacturing, its barriers to adoption, and how regulators can help standardize use across the industry. Registration is free thanks to the support of Atum Bio. |
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
|
| Webinar: Improve Bioprocess Freezing Outcomes with Analytics and Testing Services | Join us on August 26th to learn how reducing early phase inefficiencies can lower initial investments, significantly lower operations costs, and increase productivity. We will share case studies focused on benchmark testing, using surrogate materials, controlled rate freezing, and at line analytics, to identify potential impacts critical to quality, faster and without extensive analytic burden. Click here to learn more. |
|
|
|
|
|
| Complex protein-based therapies don’t play by the same process-engineering rules as small molecules and traditional biologics. They require developers to see the unforeseen and embrace new roles and responsibilities in sourcing raw materials and outsourced expertise. Successful developers can’t let this winding road slow their time to IND. Join Bioprocess Online Live on August 8th for an interactive discussion on early workflow considerations for complex protein-based therapeutics. Supported by Thermo Fisher Scientific. |
|
|
| Connect With Bioprocess Online: |
|
|
|
